Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03875079 |
|---|---|
| Brief Title: | A Study To Evaluate Safety And Therapeutic Activity Of RO6874281 In Combination With Pembrolizumab, In Participants With Advanced Or Metastatic Melanoma |
| First Submitted : | March 13, 2019 |
| First Submitted that Met QC Criteria : | March 13, 2019 |
| First Posted : | March 14, 2019 |
| Last Update Submitted that Met QC Criteria : | March 28, 2023 |
| Last Update Posted : | March 29, 2023 |